Effectiveness of women-led community interventions in improving tuberculosis preventive treatment in children: results from a comparative, before-after study in Ethiopia.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
21 07 2022
Historique:
entrez: 21 7 2022
pubmed: 22 7 2022
medline: 26 7 2022
Statut: epublish

Résumé

Our objective was to evaluate the impact of a service delivery model led by membership-based associations called Iddirs formed by women on tuberculosis preventive treatment (TPT) initiation and completion rates among children. Comparative, before-and-after study design. Three intervention and two control districts in Ethiopia. Children who had a history of close contact with adults with infectious forms of tuberculosis (TB). Child contacts in whom active TB and contraindications to TPT regimens were excluded were considered eligible for TPT. Between July 2020 and June 2021, trained women Iddir members visited households of index TB patients, screened child household contacts for TB, provided education and information on the benefits of TPT, linked them to the nearby health centre and followed them at home for TPT adherence and side effects. Two control zones received the standard of care, which comprised of facility-based provision of TPT to children. We analysed quarterly TPT data for treatment initiation and completion and compared intervention and control zones before and after the interventions and tested for statistical significance using Poisson regression. There were two primary outcome measures: proportion of eligible children initiated TPT and proportion completed treatment out of those eligible. TPT initiation rate among eligible under-15-year-old children (U15C) increased from 28.7% to 63.5% in the intervention zones, while it increased from 34.6% to 43.2% in the control zones, and the difference was statistically significant (p<0.001). TPT initiation rate for U5C increased from 13% (17 out of 131) to 93% (937 out of 1010). Of the U5C initiated, 99% completed treatment; two discontinued due to side effects; three parents refused to continue; and one child was lost to follow-up. Women-led Iddirs contributed to significant increase in TPT initiation and completion rates. The model of TPT delivery should be scaled-up.

Identifiants

pubmed: 35863840
pii: bmjopen-2022-062298
doi: 10.1136/bmjopen-2022-062298
pmc: PMC9310159
doi:

Substances chimiques

Antitubercular Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e062298

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

PLoS One. 2020 Jul 20;15(7):e0235825
pubmed: 32687506
PLoS One. 2017 Aug 1;12(8):e0182185
pubmed: 28763500
Int J Tuberc Lung Dis. 2015 Aug;19(8):898-903
pubmed: 26162354
Global Health. 2019 Mar 26;15(1):24
pubmed: 30914055
J Paediatr Child Health. 2019 Mar;55(3):278-284
pubmed: 30604557
J Clin Tuberc Other Mycobact Dis. 2018 Jan 28;10:29-31
pubmed: 31720382
Int J Tuberc Lung Dis. 2013 Feb;17(2):163-8
pubmed: 23317950
Springerplus. 2014 Apr 15;3:189
pubmed: 24790831
Matern Child Nutr. 2019 Jul;15(3):e12765
pubmed: 30516880
BMC Public Health. 2018 Feb 14;18(1):258
pubmed: 29444660
PLoS Med. 2016 Oct 25;13(10):e1002152
pubmed: 27780211
PLoS One. 2019 May 17;14(5):e0217104
pubmed: 31100097
Public Health Action. 2015 Jun 21;5(2):93-8
pubmed: 26400376
Int J Infect Dis. 2019 Dec;89:122-127
pubmed: 31639521
Int J Tuberc Lung Dis. 2017 Sep 1;21(9):1002-1007
pubmed: 28826449
PLoS One. 2013 May 27;8(5):e63174
pubmed: 23723975
BMC Infect Dis. 2020 Apr 21;20(1):294
pubmed: 32664847
BMC Infect Dis. 2018 Nov 19;18(1):587
pubmed: 30453946
Public Health Action. 2021 Jun 21;11(2):97-100
pubmed: 34159070
Lancet Infect Dis. 2021 Dec;21(12):1701-1712
pubmed: 34363771
PLoS One. 2011;6(11):e26452
pubmed: 22069451
Annu Rev Public Health. 2018 Apr 1;39:453-469
pubmed: 29328877
Acta Paediatr. 2007 Apr;96(4):582-9
pubmed: 17306012
PLoS One. 2016 May 19;11(5):e0155525
pubmed: 27196627
Ann Glob Health. 2021 Nov 15;87(1):109
pubmed: 34824990
Int J Epidemiol. 2015 Jun;44(3):966-8
pubmed: 26082408
Trop Med Infect Dis. 2020 Apr 16;5(2):
pubmed: 32316300
Int J Tuberc Lung Dis. 2018 Nov 1;22(11):1314-1321
pubmed: 30355411
Northeast Afr Stud. 2000;7(2):35-57
pubmed: 18274015

Auteurs

Degu Jerene (D)

TB Elimination and Health Systems Innovation, KNCV Tuberculosis Foundation, Den Haag, The Netherlands degujerene@gmail.com.

Dawit Assefa (D)

KNCV Tuberculosis Foundation, Ethiopia Country Office, Addis Ababa, Ethiopia.

Kalkidan Tesfaye (K)

Love in Action Ethiopia, Addis Ababa, Ethiopia.

Samuel Bayu (S)

KNCV Tuberculosis Foundation, Ethiopia Office, Addis Ababa, Ethiopia.

Samuel Seid (S)

KNCV Tuberculosis Foundation, Ethiopia Country Office, Addis Ababa, Ethiopia.

Fikirte Aberra (F)

Southern Nations Nationalities and Peoples' Region Health Bureau, Hawassa, Ethiopia.

Ahmed Bedru (A)

KNCV Tuberculosis Foundation, Ethiopia Country Office, Addis Ababa, Ethiopia.

Amera Khan (A)

Innovation & Grants, Stop TB Partnership, Geneva, Switzerland.

Jacob Creswell (J)

Innovation & Grants, Stop TB Partnership, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH